Literature DB >> 27451450

Consumption of a Bifidobacterium bifidum Strain for 4 Weeks Modulates Dominant Intestinal Bacterial Taxa and Fecal Butyrate in Healthy Adults.

Giorgio Gargari1, Valentina Taverniti1, Silvia Balzaretti1, Chiara Ferrario1, Claudio Gardana2, Paolo Simonetti2, Simone Guglielmetti3.   

Abstract

UNLABELLED: Modulation of the intestinal microbial ecosystem (IME) is a useful target to establish probiotic efficacy in a healthy population. We conducted a randomized, double-blind, crossover, and placebo-controlled intervention study to determine the impact of Bifidobacterium bifidum strain Bb on the IME of adult healthy volunteers of both sexes. High-throughput 16S rRNA gene sequencing was used to characterize the fecal microbiota before and after 4 weeks of daily probiotic cell consumption. The intake of approximately one billion live B. bifidum cells affected the relative abundance of dominant taxa in the fecal microbiota and modulated fecal butyrate levels. Specifically, Prevotellaceae (P = 0.041) and Prevotella (P = 0.034) were significantly decreased, whereas Ruminococcaceae (P = 0.039) and Rikenellaceae (P = 0.010) were significantly increased. We also observed that the probiotic intervention modulated the fecal concentrations of butyrate in a manner dependent on the initial levels of short-chain fatty acids (SCFAs). In conclusion, our study demonstrates that a single daily administration of Bifidobacterium bifidum strain Bb can significantly modify the IME in healthy (not diseased) adults. These findings demonstrate the need to reassess the notion that probiotics do not influence the complex and stable IME of a healthy individual. IMPORTANCE: Foods and supplements claimed to contain health-promoting probiotic microorganisms are everywhere these days and mainly intended for consumption by healthy people. However, it is still debated what actual effects probiotic products may have on the healthy population. In this study, we report the results of an intervention trial aimed at assessing the modifications induced in the intestinal microbial ecosystem of healthy adults from the consumption of a probiotic product. Our results demonstrate that the introduction of a probiotic product in the dietary habits of healthy people may significantly modify dominant taxa of the intestinal microbiota, resulting in the modulation of short-chain fatty acid concentrations in the gut. The overall changes witnessed in the probiotic intervention indicate a mechanism of microbiota modulation that could have potential effects on human health.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27451450      PMCID: PMC5038021          DOI: 10.1128/AEM.01753-16

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  70 in total

Review 1.  Potential role of the intestinal microbiota in programming health and disease.

Authors:  Olivier Goulet
Journal:  Nutr Rev       Date:  2015-08       Impact factor: 7.110

2.  Gut Microbiota Community and Its Assembly Associated with Age and Diet in Chinese Centenarians.

Authors:  Fang Wang; Ting Yu; Guohong Huang; Da Cai; Xiaolin Liang; Haiyan Su; Zhenjun Zhu; Danlei Li; Yang Yang; Peihong Shen; Ruifeng Mao; Lian Yu; Mouming Zhao; Quanyang Li
Journal:  J Microbiol Biotechnol       Date:  2015-08       Impact factor: 2.351

3.  Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality.

Authors:  Yanfei Chen; Jing Guo; Guirong Qian; Daiqiong Fang; Ding Shi; Lihua Guo; Lanjuan Li
Journal:  J Gastroenterol Hepatol       Date:  2015-09       Impact factor: 4.029

4.  A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.

Authors:  Ben P Willing; Johan Dicksved; Jonas Halfvarson; Anders F Andersson; Marianna Lucio; Zongli Zheng; Gunnar Järnerot; Curt Tysk; Janet K Jansson; Lars Engstrand
Journal:  Gastroenterology       Date:  2010-10-08       Impact factor: 22.682

5.  Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats.

Authors:  Sophie Bourdu; Michel Dapoigny; Eric Chapuy; Fabrice Artigue; Marie-Paule Vasson; Pierre Dechelotte; Gilles Bommelaer; Alain Eschalier; Denis Ardid
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

6.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

7.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment.

Authors:  Xochitl C Morgan; Timothy L Tickle; Harry Sokol; Dirk Gevers; Kathryn L Devaney; Doyle V Ward; Joshua A Reyes; Samir A Shah; Neal LeLeiko; Scott B Snapper; Athos Bousvaros; Joshua Korzenik; Bruce E Sands; Ramnik J Xavier; Curtis Huttenhower
Journal:  Genome Biol       Date:  2012-04-16       Impact factor: 13.583

8.  Seasonal variation in human gut microbiome composition.

Authors:  Emily R Davenport; Orna Mizrahi-Man; Katelyn Michelini; Luis B Barreiro; Carole Ober; Yoav Gilad
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

9.  The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization.

Authors:  A N Payne; C Chassard; M Zimmermann; P Müller; S Stinca; C Lacroix
Journal:  Nutr Diabetes       Date:  2011-07-18       Impact factor: 5.097

10.  Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children.

Authors:  Dae-Wook Kang; Jin Gyoon Park; Zehra Esra Ilhan; Garrick Wallstrom; Joshua Labaer; James B Adams; Rosa Krajmalnik-Brown
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

View more
  21 in total

1.  An In Vitro Enrichment Strategy for Formulating Synergistic Synbiotics.

Authors:  Car Reen Kok; David Fabian Gomez Quintero; Clement Niyirora; Devin Rose; Amanda Li; Robert Hutkins
Journal:  Appl Environ Microbiol       Date:  2019-08-01       Impact factor: 4.792

2.  Herbal Formula-3 ameliorates OVA-induced food allergy in mice may via modulating the gut microbiota.

Authors:  Sheng Liu; Bo Yang; Pingchang Yang; Zhigang Liu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  The Effects of Supplementation with Probiotic on Biomarkers of Oxidative Stress in Adult Subjects: a Systematic Review and Meta-analysis of Randomized Trials.

Authors:  Behzad Zamani; Ali Sheikhi; Nazli Namazi; Bagher Larijani; Leila Azadbakht
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

Review 4.  Gut Vibes in Parkinson's Disease: The Microbiota-Gut-Brain Axis.

Authors:  Clara Bullich; Ali Keshavarzian; Johan Garssen; Aletta Kraneveld; Paula Perez-Pardo
Journal:  Mov Disord Clin Pract       Date:  2019-10-23

5.  Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial.

Authors:  Cesare Cremon; Simone Guglielmetti; Giorgio Gargari; Valentina Taverniti; Anna Maria Castellazzi; Chiara Valsecchi; Carlotta Tagliacarne; Walter Fiore; Massimo Bellini; Lorenzo Bertani; Dario Gambaccini; Michele Cicala; Bastianello Germanà; Maurizio Vecchi; Isabella Pagano; Maria Raffaella Barbaro; Lara Bellacosa; Vincenzo Stanghellini; Giovanni Barbara
Journal:  United European Gastroenterol J       Date:  2017-10-08       Impact factor: 4.623

6.  Microbiome restoration diet improves digestion, cognition and physical and emotional wellbeing.

Authors:  Kate Lawrence; Jeannette Hyde
Journal:  PLoS One       Date:  2017-06-14       Impact factor: 3.240

7.  Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study.

Authors:  Talia Palacios; Luis Vitetta; Samantha Coulson; Claire D Madigan; Yan Y Lam; Rachel Manuel; David Briskey; Chelsea Hendy; Ji-Nu Kim; Thomas Ishoey; Maria J Soto-Giron; Eric M Schott; Gerardo Toledo; Ian D Caterson
Journal:  Nutrients       Date:  2020-07-09       Impact factor: 5.717

Review 8.  Resolving the Contradictory Functions of Lysine Decarboxylase and Butyrate in Periodontal and Intestinal Diseases.

Authors:  Martin Levine; Zsolt M Lohinai
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

Review 9.  Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents.

Authors:  Chun-Wei Chiu; Pei-Jane Tsai; Ching-Chi Lee; Wen-Chien Ko; Yuan-Pin Hung
Journal:  Pathogens       Date:  2021-05-24

Review 10.  Microbiota and Lifestyle: A Special Focus on Diet.

Authors:  Noemí Redondo-Useros; Esther Nova; Natalia González-Zancada; Ligia E Díaz; Sonia Gómez-Martínez; Ascensión Marcos
Journal:  Nutrients       Date:  2020-06-15       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.